ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 357288 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 357288; 2) Community: the network communities that were significantly associated with the response to NSC 357288; 3) Molecule: the relationships between components within communities and NSC 357288; 4) MDR: the compounds that were significantly associated with the NSC 357288.

NSC Compound Enrichment Correlation
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0421163101172308 0.15903736
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0421163101172308 0.22744237
NSC 237538 2,4-Thiazolidinedione, 5-(3-phenyl-2-propenylidene)- 0.0421163101172308 0.23905327
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0421163101172308 0.43712981
NSC 286193 Tiazofurin (USAN) 0.0421163101172308 0.2348106
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0421163101172308 0.093505444
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.0421163101172308 0.23771487
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0421163101172308 0.10501614
NSC 373355 Saframycin R 0.0421163101172308 0.51801824
NSC 48300 ANTINEOPLASTIC-48300 0.0421163101172308 0.49143935
Total:81  Current:72    [First] [Prev] [Next] [Last]